Grid Therapeutics is a clinical-stage biotechnology company in Durham, North Carolina, developing therapeutic antibodies for cancer and a platform to discover human-derived antibodies against tumor-specific targets.
Gerold Bepler became president and chief executive officer of the Barbara Ann Karmanos Cancer Institute in February 2010. Previously, he held leadership roles at Moffitt Cancer Center and was a professor at the University of South Florida.
Richard A. Parker is chief medical officer of Arcadia Healthcare Solutions. He was an internist at Beth Israel Deaconess Medical Center for 30 years and served as medical director and chief medical officer of Beth Israel Deaconess Care Organization from 2001 to 2015.
Dr. Cavagnaro earned a PhD in biochemistry from the University of North Carolina at Chapel Hill and worked at the US Food and Drug Administration and Covance. Her work addressed safety guidelines for biotechnology-derived therapeutics.
